CLINICAL_TRIALS trial_result · 2015-06-09

Clinical Trial Update: Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis [Phase 4]

Phase 4 clinical trial evaluating the host-modulatory effects of beta-glucan on localized aggressive periodontitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Al-Azhar University | Conditions: Localized Aggressive Periodontitis | Phase 4 | Status: COMPLETED | Results posted: 2015-06-09